flufenamic acid has been researched along with anandamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
Cravatt, BF; Hillard, CJ; Koester, EC; Moreno, M; Pazos, MR; Romero, J; Tolón, RM; Vázquez, C | 1 |
1 review(s) available for flufenamic acid and anandamide
Article | Year |
---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
1 other study(ies) available for flufenamic acid and anandamide
Article | Year |
---|---|
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.
Topics: Adenosine Triphosphate; Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Apyrase; Arachidonic Acids; Astrocytes; Brain; Brain Injuries; Connexin 43; Disease Models, Animal; Endocannabinoids; Ethanolamines; Flufenamic Acid; Glycerides; Lasers; Mice; Mice, Knockout; Mice, Transgenic; Microglia; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1 | 2015 |